Clinical Trial Update: Effect of Tumor Treating Fields (TTFields, 150kHz) Concomitant with Sorafenib for Advanced Hepatocellular Carcinoma (HCC) (HEPANOVA) [Phase 2]

View source ↗

Summary

A Phase 2 trial (HEPANOVA) evaluating Tumor Treating Fields at 150 kHz in combination with sorafenib for advanced hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: NovoCure Ltd. | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED